Advanced Hemodynamic Monitoring for Goal-directed Hemodynamic Management During Radical Cystectomy

Not Applicable

• Conditions: Radical Cystectomy; Perioperative Complications; Hemodynamic Monitoring

• Registration Number: NCT00966147
• Lead Sponsor: Hadassah Medical Organization

Brief Summary

The purpose of this study is to determine whether increasing cardiac output by a combination of intravenous fluids and inotropic drugs can reduce mortality and morbidity in radical cystectomy operations.

Detailed Description

Not available

Study Timeline

• Status Verified: 2009-07
• Study First Submitted: 2009-08-25
• Study First Submitted QC: 2009-08-25
• Last Update Submitted: 2009-08-25
• Study First Posted: 2009-08-26
• Last Update Posted: 2009-08-26
• Study Start: 2009-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Adults (>18yo) scheduled for elective radical cystectomy and ileal conduit formation

Exclusion Criteria

• Creatinine level above 200 mcg/dl
• single functioning kidney
• s/p kidney transplant
• heart rhythm other than sinus
• known allergy to lithium chloride
• chronic lithium therapy
• weight below 40 kg
• mental or language problems that precludes obtaining informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Mortality	Hospital stay

Secondary Outcome Measures

Name	Time	Method
Morbidity	Hospital stay

Trial Locations

Locations (1)

Hadassah Medical Organization, Jerusalem, Israel; 🇮🇱 Jerusalem, Israel